North Dakota's medical marijuana program sold $22.4 million in fiscal year 2024 through eight dispensaries supplied by exactly two manufacturers — the maximums state law permits without a regulatory finding that has never been made. Under the framework's assumptions, the legal channel captures roughly 11% of
Iowans spend an estimated three-quarters of a billion dollars a year on cannabis. About $13.7 million of it — 1.8% — passes through the state's five licensed dispensaries. The rest, roughly $760 million annually — about $2.1 million every day — is spending Iowa's medical channel
Louisiana's medical cannabis program runs on just two licensed producers supplying a hard-capped 30 dispensaries statewide. Wholesale distribution to pharmacies reached an estimated $90.9 million in the year ending June 2025 — a figure independently confirmed two ways, once by state tax collections and once by industry
Washington DC voters approved cannabis legalization in 2014 with 70% of the vote. Eleven years later, the city still has no licensed adult-use market. What it has instead is a medical program that functions as a de facto adult-use channel for anyone willing to register, a "gifting&
Missouri's cannabis market generated $1.52 billion in 2025 — $1.34 billion adult-use, $174 million medical — against an estimated resident demand the framework puts near 280 million grams. That works out to a blended price of about $5.42 per gram and resident capture north of 90%
Washington legalized adult-use cannabis in 2012 alongside Colorado and is now the clearest case study in what a mature, oversupplied, commodity-floor market looks like. FY2025 legal sales of roughly $1.18 billion against an estimated 387.6 million grams of resident demand work out to a blended all-
Mississippi's medical cannabis program generated $138.9M in CY 2025 across 66,041 active patient cardholders, capturing an estimated 16% of modeled demand at $6.43/g flower pricing. The third-year program is growing strongly — sales up 43.8% year-over-year, with patient enrollment up 33%
Utah's medical cannabis program serves 113,202 active cardholders across 15 dispensaries — a retail footprint so constrained that statewide remote-order channels handle roughly a third of all sales. After six years of operation, the program runs at a $183M annualized pace and has generated $750M in cumulative
Alaska legalized adult-use cannabis through Ballot Measure 2 in 2014, with the first licensed sales in 2016. A decade later it captures an estimated 95% of resident demand — among the highest rates of any market — for a reason almost no other state shares: geographic isolation raises the cost of
Arizona launched adult-use cannabis sales on January 22, 2021 — 80 days after the election, the fastest implementation of a voter-approved legalization measure in U.S. history. Four years later, the state generated $1.22 billion in combined medical and adult-use sales in 2025 against a resident consumer
West Virginia has 64 operational dispensaries, 9 growers, and a medical cannabis program that generated an estimated $93 million in 2025 — all serving approximately 35,000 registered patients in one of the poorest states in the country. Prices have fallen 15.4% in two years as indoor-only producers compete
Arkansas has run a medical cannabis program since 2019 and generated $291 million in sales in 2025 — a new state record. The math behind that number is unusual: approximately 110,000 active patient cardholders, each spending roughly $210/month, are carrying the entire regulated market. The other three-quarters of
Vermont launched adult-use retail in October 2022 with a regulatory framework built around small-scale outdoor cultivators, sustainability, and deliberate market development. About nine months after launch, catastrophic flooding hit the state's predominantly outdoor cultivation base and drove prices up through mid-2024. Vermont is the only
Oklahoma passed SQ 788 in 2018 with no qualifying condition list — patients need only a recommendation from an OMMA-registered physician in good standing. The result is a medical program that functions as adult use in everything but name: $2.11/g flower, 1,398 licensed dispensaries, and the lowest
New Mexico peaked at $590 million in 2024 and is now declining. But the headline number obscures two separate stories: 61.9% flower price compression since launch, and a border export market that has grown 301% since launch and now accounts for nearly 20% of all state revenue. Market Overview
Nevada's cannabis market peaked at $965 million in FY22 and has declined 28% to a $695 million annualized pace. But the decline isn't a failure — it's what happens after you've already captured every gram of resident demand and prices keep falling. Market
New Jersey's cannabis market crossed $1 billion in 2024 and is on pace for $1.16 billion in 2025 — but volume is the story, not revenue. Adult-use flower prices have fallen 35% in 21 months while grams sold have increased 38%. Market Overview New Jersey legalized adult-
New York's cannabis market generated $1.48 billion in adult-use sales through November 2025 across 519 dispensaries. Despite this, the state captures an estimated 16% of total demand. The OCM's own reports are the most analytically sophisticated in the country, and they confirm what the
Rhode Island's cannabis market generates $120 million in annual sales through just eight dispensaries — the second most under-licensed market in the country behind Virginia. With 60% of demand going to Massachusetts border dispensaries and the illicit market, the state's incumbents are lobbying to block new
Hawaii's medical cannabis program generates approximately $64 million in annual sales through 8 licensed dispensary operators running 25 retail locations to serve 1.45 million residents across an island chain where some patients drive 70 minutes to the nearest store and others need an airplane. The state has
Virginia legalized possession and home cultivation in July 2021. Adults can hold an ounce, grow four plants, and share freely. What they cannot do — five years later — is walk into a store and buy cannabis. The legislature deferred the retail framework. Governor Youngkin vetoed every attempt to establish one. The
A consumption-data reality check on cannabis psychosis — examining what population-level evidence actually shows about the link between cannabis, schizophrenia, and mental health. In 2026, a growing chorus of researchers, policymakers, and media commentators warn that high-potency cannabis is driving a psychosis epidemic. The framing is urgent: today&
Montana launched adult-use sales January 1, 2022 with 557 dispensaries — 49.2 per 100,000 residents, one of the highest per-capita density of any state studied. Four years later the state captures 107% of resident demand. The surplus isn't a math error. It's 13.
Pennsylvania operates the most successful medical-only cannabis program in the United States — 439,381 active patients, $9.05 billion in cumulative sales, 49% retail price compression since 2021, and 35% legal capture without a single adult-use transaction. Five of six border states have legalized adult-use cannabis. The